Dentists in Moose Lake, MN Accepting Medicare
4 Dentists found. Showing 1 - 4
 Dr. James Clinton Hubred, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 304 Elm Ave., Moose Lake, MN 55767 Phone: 218-485-4455 |
Dr. Michael Gunnarson, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 75 Arrowhead Ln, Moose Lake, MN 55767 Phone: 218-485-4615 |
Dr. Laurence Edward Will Jr., DDS Dentist - Dental Public Health Medicare: Not Enrolled in Medicare Practice Location: 1000 Lakeshore Dr, Moose Lake, MN 55767 Phone: 218-485-5100 |
Dr. Kurt David Stodola, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 304 Elm Ave., Moose Lake, MN 55767 Phone: 218-485-4455 |
News Archive
New silicone chip could make genetic analysis far more sensitive, rapid, and cost-effective
UBC researchers have invented a silicone chip that could make genetic analysis far more sensitive, rapid, and cost-effective by allowing individual cells to fall into place like balls in a pinball machine.
Researchers may have discovered the key to treating inflammatory diseases
A Rutgers-led team may have found the key to treating inflammatory diseases like asthma, allergies, chronic fibrosis and chronic obstructive pulmonary disease (COPD).
Stopping Aspirin may raise heart attack death risk by 60%: Study
The study results revealed that patients with a history of heart disease who stopped taking a low-dose daily aspirin had a 60% increased risk of having a heart attack over the three-year follow-up, compared with patients who continued the daily aspirin, says study researcher Luis A. Garcia Rodriguez, director of the Spanish Center for Pharmacoepidemiologic Research (CEIFE) in Madrid. The study is published in the British Medical Journal.
College athletes experiencing in-season shoulder instability return to play within 1 week
College athletes experiencing in-season shoulder instability regularly return to play within one week of injury, but developed recurrent instability in 63% of cases, according to research presented today at the American Orthopaedic Society for Sports Medicine's (AOSSM) Annual Meeting.
Positive results from OMS201 Phase 1/2 trial in patients undergoing urologic procedures
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced results from the Phase 1/2 clinical trial of OMS201, the Company's urological PharmacoSurgery™ product candidate.
› Verified 4 days ago
Occupational Therapists
Pharmacists
Counselors
Dentists
Clinical Social Workers
Psychologists